Sanofi Is Composing Emerging Markets Strategy: Latest Acquisition Is Brazilian Medley For $686M
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi’s acquisition of Medley, Brazil’s largest generics company, reinforces its increasingly aggressive expansion in emerging markets.
You may also be interested in...
Sanofi Finalizes Zentiva Sale With Focus Back On Turnaround
A share purchase agreement for the sale of Zentiva has been signed with private equity group Advent, so Sanofi can concentrate on making the most of its new acquisitions.
Sanofi Channel Stuffing In Brazil?
Sanofi CEO Chris Viehbacher showed clear signs of disappointment during the company’s earnings call, admitting emerging markets underperformed, and revealing a debacle in Brazil that appears to be channel stuffing.
Emerging Markets Earnings Roundup: Sanofi Channel Stuffing In Brazil? (Part 4)
Sanofi CEO Chris Viehbacher showed clear signs of disappointment during the company’s earnings call, admitting emerging markets under-performed, and revealing a debacle in Brazil that appears to be channel stuffing.